CEACAM1/CD66a rHuz mAb (Ref: Chaim Sheba Med Cntr patent)
Application
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Reactivity
Human
Target
| Target Name | CEACAM1 / CD66a |
| Target Uniprot | P13688 |
Overview
| Catalog# | BIO0506SM |
| Product Name | Anti-human CEACAM1 / CD66a (Chaim Sheba Med. Cntr. patent Anti-CEACAM1 Biosimilar) |
Specifications
| Conjugation | None |
| Formulation | 100 mM Pro-Ac 20mM Arg pH 5.0 |
| Storage | For long term storage, the produce should be stored at -20℃ or lower. |
| Reconstitution | Dissolve with sterile ddH2O |
| Concentration | Lot Dependent |
| Isotype | Human IgG1 |
| Calculated M.W. | 144.98 kDa |
| Endotoxin | <0.001 EU/ug |
| Expression System | CHO |
| Purification | Protein A |
Frequently asked questions
Which applications is CEACAM1/CD66a rHuz mAb (Ref: Chaim Sheba Med Cntr patent) (BIO0506SM) validated for, and at what dilution?
BIO0506SM is validated for In Vivo Research.